SOLENO THERAPEUTICS INC's ticker is and the CUSIP is 834203309. A total of 115 filers reported holding SOLENO THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 12.01 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $292,324 | – | 6,830 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 7,316,851 | $298,527,521 | 27.58% |
| Carlyle Group Inc. | 4,071,562 | $166,364,023 | 15.80% |
| Nantahala Capital Management | 3,082,107 | $125,749,966 | 7.40% |
| Ally Bridge Group (NY) LLC | 286,162 | $11,675,410 | 6.96% |
| COMMODORE CAPITAL LP | 1,425,000 | $58,140,000 | 3.97% |
| Ghost Tree Capital, LLC | 300,000 | $12,240,000 | 3.83% |
| Vestal Point Capital, LP | 1,200,000 | $48,960,000 | 3.65% |
| Altium Capital Management LP | 212,909 | $8,686,687 | 3.54% |
| Ikarian Capital, LLC | 445,451 | $18,174,401 | 3.17% |
| Perceptive Advisors | 3,204,976 | $130,763,021 | 3.15% |